Ccla Investment Management / EW
Ccla Investment Management’s Edwards Lifesciences Corp Position
Does Ccla Investment Management own Edwards Lifesciences Corp (EW)? Not currently — the last reported position was 1.42M shares worth $133M in Q3 2024; the fund’s latest 13F (Q4 2025) no longer reports it.
Position Value
$133M
Q3 2024
Shares
1.42M
% of Portfolio
+2.04%
Quarters Held
16
position exited
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2024 | 1.42M | $133M | +2.04% |
| Q2 2024 | 1.42M | $133M | +2.04% |
| Q1 2024 | 1.41M | $134M | +2.06% |
| Q4 2023 | 1.4K | $107M | +1.75% |
| Q3 2023 | 1.28M | $89M | +1.66% |
| Q2 2023 | 1.26M | $118M | +2.11% |
| Q1 2023 | 1.16M | $96M | +1.89% |
| Q4 2022 | 1.07M | $80M | +1.80% |
| Q3 2022 | 807.5K | $67M | +1.62% |
| Q1 2022 | 803.0K | $95M | +1.70% |
| Q4 2021 | 790.8K | $102M | +1.68% |
| Q3 2021 | 837.9K | $95M | +1.57% |
| Q2 2021 | 753.2K | $78M | +0.95% |
| Q1 2021 | 564.6K | $47M | +0.94% |
| Q4 2020 | 432.6K | $39M | +0.88% |
| Q3 2020 | 428.8K | $34M | +0.93% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ccla Investment Management’s full portfolio or all institutional holders of EW.